Patent details

Basic Information

Publication number:

EP3863628

PCT Application Number:

US2019055167

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP197943665

PCT Publication Number:

WO2020076809

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATION OF IBUDILAST AND INTERFERON-BETA AND METHODS OF USING SAME

French Title of Invention:

COMBINAISON DE L'IBUDILAST ET DE L'INTERFÉRON-BETA ET MÉTHODES DE SON UTILISATION

German Title of Invention:

KOMBINATION VON IBUDILAST UND INTERFERON-BETA UND METHODEN ZU DEREN VERWENDUNG

SPC Number:

Dates

Filing date:

08/10/2019

Grant date:

27/12/2023

EP Publication Date:

18/08/2021

PCT Publication Date:

16/04/2020

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

27/12/2023

EP B1 Publication Date:

27/12/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

08/10/2039

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

20/12/2023

 

 

Name:

MediciNova, Inc.

Address:

4275 Executive Square Suite 300, La Jolla, CA 92037, United States (US)

Inventor

Name:

MATSUDA, Kazuko

Address:

United States (US)

Priority

Priority Number:

201862743449 P

Priority Date:

09/10/2018

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/437; A61K 38/21; A61P 25/00;

Publication

European Patent Bulletin

Issue number:

202352

Publication date:

27/12/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

30/04/2025

Annual Fee Number:

6

Annual Fee Amount:

66 Euro

Penalty Fee Amount:

20 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages